May 4, 2017 / 11:15 AM / 3 months ago

BRIEF-Keryx Biopharmaceuticals Q1 loss per share $0.21

May 4 (Reuters) - Keryx Biopharmaceuticals Inc:

* Keryx Biopharmaceuticals announces first quarter 2017 financial results

* Q1 loss per share $0.21

* Q1 revenue $11.8 million versus I/B/E/S view $10.3 million

* Q1 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S

* Sees for full year 2017 net u.s. Auryxia product sales of $56 to $60 million

* Keryx biopharmaceuticals - q1 2017 net u.s. Auryxia product sales of $10.5 million versus $5.6 million in q1 of 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below